Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sea cucumber glycosaminoglycan injection in acute ischemic stroke
CTR20192370Phase 3Completed
- Sponsor
- Harbin Taxus Bio-Pharmaceutical
- Start
- Mar 2020
- Countries
- 1
01
Overview
A Phase 3 trial of sea cucumber glycosaminoglycan in ischemic stroke, brain infarction, sponsored by Harbin Taxus Bio-Pharmaceutical. Started Mar 2020; status: completed.
02
Drugs
sea cucumber glycosaminoglycan
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on CTR20192370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192370.